Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models
Dmitri Pchejetski(University of East Anglia), Olivier Cuvillier(Centre National de la Recherche Scientifique), Bernard Malavaud(Université Toulouse III - Paul Sabatier), Justin Teissié(Centre National de la Recherche Scientifique), N. Doumerc(Hôpital Rangueil), Maria Naymark(The London College), Takafumi Kohama(Daiichi-Sankyo (Japan)), Jonathan Waxman, Muriel Golzio(Centre National de la Recherche Scientifique)
Cited by 117
Related Papers
Recommendations guidelines on the key information to be reported in studies of application of PEF technology in food and biotechnological processes
|Innovative Food Science & Emerging Technologies|2016|296
Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity
|Nature Communications|2016|287
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
|Cancer Research|2005|203
Oxidative Stress–Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A–Associated Cardiac Cell Apoptosis
|Circulation Research|2006|197
The emerging role of FTY720 (Fingolimod) in cancer treatment
|Oncotarget|2016|174